Health Catalyst (HCAT.US): The 2024 Q1 financial report achieved revenue of US$74.723 million, prior value of US$73.868 million, expected value of US$74.8 million; earnings per share were US$0.05, previous value was US$0.05, and expected value was US$0.03.
Health Catalyst(HCAT.US)：2024年Q1财报实现营收7472.3万美元，前值为7386.8万美元，预期值为7480万美元；每股收益为0.05美元，前值为0.05美元，预期值为0.03美元。
Health Catalyst (HCAT.US): The 2024 Q1 financial report achieved revenue of US$74.723 million, prior value of US$73.868 million, expected value of US$74.8 million; earnings per share were US$0.05, previous value was US$0.05, and expected value was US$0.03
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.